Pharma company Roche are planning a clinical trial of tocilizumab (TCZ) with GCA to start in a few months time. TCZ has been trialled with success in the treatment of RA (rheumatoid arthritis). The objective of the GCA trial is to gather data on whether using TCZ alongside pred can enable the patient to taper the pred dose more quickly, and take fewer steroids over the course of their illness. They will be seeking to recruit people over 50 with GCA which is 'active' and who would be willing to undergo weekly injections for at least a year. Interested? Drop us an email!
We wish to emphasise that in putting this information into the public domain, PMRGCAuk are not endorsing the product or the company concerned. We simply wish to carry out one of our charitable objectives which is to encourage research into the causes and treatment of PMR and GCA.